The decision by Aspen CEO Stephen Saad to defy his bankers 21 years ago and keep, rather than sell, a Port Elizabeth drugs manufacturing facility means the company is ready to play a key global role in the manufacture of a vaccine against Covid-19.

A deal unveiled this week with the $400bn US pharmaceutical giant Johnson & Johnson (J&J) positions Aspen to be at the forefront of the battle against the pandemic, which is forcing a growing number of countries back into debilitating lockdowns...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now